F B Abwicklungsgesellschaft mbHLiquidated

Master Data

Basic information of the organization

Registry

FRIZ Biochem GmbH

Registered

8/16/1999

IndustryClassified using Destatis WZ standard, derived from commercial register and web data by Fusionbase AI.

Research and experimental development on biotechnologyResearch and experimental development on biotechnologyWZ 72.10.1PrimaryManufacture of testing machinesManufacture of testing machinesWZ 26.51.3Manufacture of irradiation, electromedical and electrotherapeutic equipmentManufacture of irradiation, electromedical and electrotherapeutic equipmentWZ 26.60.0

Purpose

Entwicklung und Vertrieb von Analysesystemen zur parallelen Detektion verschiedener Desoxyribonukleinsäuren sogenannten DNA-Chips, mit direktem elektrischen Ausleseverfahren.

History

Changes published in the official company registry

No events found for this filter

Management

Legal representatives of the organization

Name	Role	Entry Date
Gerhard Dr. Hartwich since 10/23/2001	Managing Director	10/23/2001

Beneficial Owners

Natural persons who ultimately own or control the company, resolved through the shareholder chain

Beneficial owner data is only accessible to registered users.

Shareholders

Company ownership and partner structure

6 shareholders

GmbH structure

3 of 6 shown

Gerhard Hartwich

—

€14,400

30.13%

Global Life Science Holding XI GmbH

Germany

€13,150

27.51%

tbg Technologie-Beteiligungs-Gesellschaft mbH

Germany

€11,800

24.69%

News & Media Coverage

Insolvency Notices

Real-time check for insolvency notices from register courts

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Real-time document download from the commercial register

Shareholder List

Current Print (Aktueller Abdruck)

Chronological Print (Chronologischer Abdruck)